Abstract
AbstractThe process of epigenetic silencing, while fundamentally important, is not yet completely understood. Here we report a replenishable female mouse embryonic stem cell (mESC) system, Xmas, that allows rapid assessment of X chromosome inactivation (XCI), the epigenetic silencing mechanism of one of the two X chromosomes that enables dosage compensation in female mammals. Through a targeted genetic screen in differentiating Xmas mESCs, we reveal that the BAF complex is required to create nucleosome-depleted regions at promoters on the inactive X chromosome during the earliest stages of establishment of XCI. Without this action gene silencing fails. Xmas mESCs provide a tractable model for screen-based approaches that enable the discovery of unknown facets of the female-specific process of XCI and epigenetic silencing more broadly.
Funder
Department of Health | National Health and Medical Research Council
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary
Reference123 articles.
1. Gendrel, A. V. & Heard, E. Fifty years of X-inactivation research. Development 138, 5049–5055 (2011).
2. Jegu, T., Aeby, E. & Lee, J. T. The X chromosome in space. Nat. Rev. Genet 18, 377–389 (2017).
3. Disteche, C. M. & Berletch, J. B. X-chromosome inactivation and escape. J. Genet 94, 591–599 (2015).
4. Brockdorff, N. & Turner, B. M. Dosage compensation in mammals. Cold Spring Harb. Perspect. Biol. 7, a019406 (2015).
5. Monk, M. & McLaren, A. X-chromosome activity in foetal germ cells of the mouse. J. Embryol. Exp. Morphol. 63, 75–84 (1981).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献